|Title:||Bicyclic heteroaromatic compounds as protein tyrosine kinase inhibitors|
|Abstract:|| A pharmaceutical formulation comprising the compound of formula ##STR00001##|
|Inventor(s):|| Carter; Malcolm Clive (Stevenage, GB), Cockerill; George Stuart (Stevenage, GB), Lackey; Karen Elizabeth (Durham, NC) |
|Assignee:|| Novartis AG (Basel, CH) |
|Filing Date:||Nov 10, 2014|
|Claims:||1. A method of treating breast cancer by administering a pharmaceutical formulation presented in unit dose form comprising the compound of formula ##STR00055## as an active ingredient, wherein said active ingredient is present within said unit dose form in an amount from 0.5 mg to 1 g. |
2. The method of claim 1, wherein the pharmaceutical formulation is administered as a single dose per day.
3. The method of claim 1, wherein the pharmaceutical formulation is administered as a number of sub-doses per day.
4. The method of claim 1, wherein said unit dose is a tablet.